Krahn Martin, Labelle Véronique, Borges Ana, Bartoli Marc, Lévy Nicolas
Genet Test Mol Biomarkers. 2010 Feb;14(1):153-4. doi: 10.1089/gtmb.2009.0131.
Mutations in the gene encoding dysferlin (DYSF; MIM# 603009, 2p13, GenBank NM_003494.2) cause primary dysferlinopathies, which are autosomal recessive muscular dystrophies. DYSF has a large mutational spectrum, and genetic diagnosis is complicated by incomplete mutation detection rates. Recently, novel dysferlin transcripts were characterized by identifying alternative exons 1 of DYSF-v1 (GenBank DQ267935), exon 5a (GenBank DQ976379), and exon 40a (GenBank EF015906). To evaluate the frequency of possible mutations in the newly identified DYSF alternative exons, we screened the corresponding genomic regions for mutations in a cohort of 26 patients, carrying only one mutation undoubtedly considered as disease causing in the 55 canonical DYSF exons. No disease-causing mutation was identified in alternative exons 1 of DYSF-v1, exon 5a, and exon 40a, demonstrating a low frequency of disease-causing mutations in these exons.
编码dysferlin(DYSF;MIM# 603009,2p13,GenBank NM_003494.2)的基因突变会导致原发性dysferlin病,这是一种常染色体隐性遗传性肌肉萎缩症。DYSF具有广泛的突变谱,且由于突变检测率不完整,基因诊断变得复杂。最近,通过鉴定DYSF-v1(GenBank DQ267935)的替代外显子1、外显子5a(GenBank DQ976379)和外显子40a(GenBank EF015906)对新型dysferlin转录本进行了表征。为了评估新鉴定的DYSF替代外显子中可能的突变频率,我们在一组26例患者中筛查了相应基因组区域的突变,这些患者在55个典型DYSF外显子中仅携带一个无疑被视为致病的突变。在DYSF-v1的替代外显子1、外显子5a和外显子40a中未鉴定出致病突变,表明这些外显子中致病突变的频率较低。